| First Author | Guinea-Viniegra J | Year | 2012 |
| Journal | J Clin Invest | Volume | 122 |
| Issue | 8 | Pages | 2898-910 |
| PubMed ID | 22772468 | Mgi Jnum | J:190075 |
| Mgi Id | MGI:5447911 | Doi | 10.1172/JCI63103 |
| Citation | Guinea-Viniegra J, et al. (2012) Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. J Clin Invest 122(8):2898-910 |
| abstractText | Squamous cell carcinomas (SCCs) are heterogeneous and aggressive skin tumors for which innovative, targeted therapies are needed. Here, we identify a p53/TACE pathway that is negatively regulated by FOS and show that the FOS/p53/TACE axis suppresses SCC by inducing differentiation. We found that epidermal Fos deletion in mouse tumor models or pharmacological FOS/AP-1 inhibition in human SCC cell lines induced p53 expression. Epidermal cell differentiation and skin tumor suppression were caused by a p53-dependent transcriptional activation of the metalloprotease TACE/ADAM17 (TNF-alpha-converting enzyme), a previously unknown p53 target gene that was required for NOTCH1 activation. Although half of cutaneous human SCCs display p53-inactivating mutations, restoring p53/TACE activity in mouse and human skin SCCs induced tumor cell differentiation independently of the p53 status. We propose FOS/AP-1 inhibition or p53/TACE reactivating strategies as differentiation-inducing therapies for SCCs. |
